Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

June 30, 2015 5:43 AM ET

Company Overview of Health Care Institute of New Jersey

Company Overview


United States

Key Executives for Health Care Institute of New Jersey

Chief Executive Officer and President
Age: 70
Vice Chairman for Pharmaceuticals and Chair of the Membership Committee of the Board of Trustees
Age: 59
Age: 59
Board Secretary
Compensation as of Fiscal Year 2014.

Health Care Institute of New Jersey Key Developments

Healthcare Institute of New Jersey Announces Management Changes

The HealthCare Institute of New Jersey (HINJ) has announced new officers of its Board of Trustees as well as the leadership of its Steering Committee. Craig B. Bleifer, Vice President, General Counsel and Secretary, Daiichi Sankyo Inc., has been named as Chair of the HINJ Board of Trustees. Mr. Bleifer, who previously served as a Vice Chair of the HINJ Board, is responsible for the oversight of Daiichi Sankyo's Legal Affairs, Intellectual Property, Commercial Regulatory Affairs, Government Affairs and Public Policy, and Public Affairs departments. Mr. Bleifer and his team support commercial, clinical and corporate activities in the U.S. and globally. Mr. Bleifer succeeds Kevin T. Rigby, U.S. Country Head Public Affairs, Vice President Public Affairs, Novartis Pharmaceuticals Corporation. Mr. Rigby will continue to serve on the Board. At its June 13 meeting, the HINJ Board elected two new Vice Chairs: Yin C. Becker, Vice President, Communications, Public Affairs and Strategic Marketing, Stryker. Raymond Sacchetti, Senior Vice President, U.S. Access and Government Affairs, Bristol-Myers Squibb Company. In addition, Jeffrey S. Sherman, Senior Vice President and General Counsel, BD, continues to serve as Treasurer, and Lisa M. Goldman, Executive Director, U.S. Oncology Ethics and Compliance, Novartis Pharmaceuticals Corporation, continues to serve as Board Secretary. HINJ also announced that Wendy M. Lazarus, Director, Government Relations and Public Affairs, Pfizer Inc., is the new Chair of HINJ's Steering Committee. Ms. Lazarus, who has served as Vice Chair, succeeds Sarah G. Kan, Associate Director, State and External Affairs, Novartis Pharmaceuticals Corporation.

Similar Private Companies By Industry

Company Name Region
IPvaani Inc. United States
Quynn Consulting LLC United States
Edgewater Power Boats, LLC United States
Malmo Bancorp, Inc. United States
B.E. Windows United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Health Care Institute of New Jersey, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at